リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Natural History of Meningiomas: Review with Meta-analyses.」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Natural History of Meningiomas: Review with Meta-analyses.

NAKASU Satoshi 00135477 0000-0001-8719-9806 NAKASU Yoko 10135478 滋賀医科大学

2020.03.15

概要

Observation has been a mainstay in asymptomatic meningiomas, but it may increase the risk associated with treatment due to tumor enlargement and the aging of patients. Understanding the natural course of meningiomas is important to provide appropriate treatment. The majority of previous studies investigated factors related to their growth, but failed to demonstrate their relationship with symptomatic progression (sympP) because of its rarity. We reviewed and meta-analyzed 27 studies that investigated natural courses in asymptomatic or untreated meningiomas to find clinico-radiological factors predictive of radiological progression (radioP), growth speed, and sympP. In results of time-growth analysis, two-thirds of meningiomas showed radioP defined by a volume criterion and the rate approached a plateau at 4-5 years. In growth curve analyses, about half of incidental meningiomas presented decelerating or no growth, while less than one-quarter of them grew exponentially. RadioP, growth speed [annual volume change (AVC) or relative growth rate], and sympP each had different factors related to them. Younger age, non-calcification, and high intensity on T2-weighted image were related to radioP and rapid growth speed, but not to sympP. Tumors in males and those of larger size were likely to be symptomatic in the meta-analysis. AVC (≥2.1 cm3/year) was the strongest indicator of sympP. Apart from perifocal edema, radiological features at up-front imaging may not be useful for predicting sympP. This may be due to dynamic changes of those radiological markers in the long term. Quantified tumor size and growth speed, especially AVC, are important markers for deciding on treatment.

この論文で使われている画像

参考文献

1) Nakasu S, Hirano A, Shimura T, Llena JF: Incidental

meningiomas in autopsy study. Surg Neurol 27:

319–322, 1987

2) Rausing A, Ybo W, Stenflo J: Intracranial meningioma—a

population study of ten years. Acta Neurol Scand

46: 102–110, 1970

3) Bos D, Poels MM, Adams HH, et al.: Prevalence,

clinical management, and natural course of incidental

findings on brain MR images: the population-based

Rotterdam scan study. Radiology 281: 507–515,

2016

4) Behbahani M, Skeie GO, Eide GE, Hausken A,

Lund-Johansen M, Skeie BS: A prospective study

of the natural history of incidental meningioma—

Hold your horses! Neuro-Oncol Pract 6: 438–450,

2019

5) Firsching RP, Fischer A, Peters R, Thun F, Klug N:

Growth rate of incidental meningiomas. J Neurosurg

73: 545–547, 1990

6) Hashiba T, Hashimoto N, Izumoto S, et al.: Serial

volumetric assessment of the natural history and

growth pattern of incidentally discovered meningiomas. J Neurosurg 110: 675–684, 2009

7) Hashimoto N, Rabo CS, Okita Y, et al.: Slower growth

of skull base meningiomas compared with nonskull base meningiomas based on volumetric and

biological studies. J Neurosurg 116: 574–580, 2012

8) Jo KW, Kim CH, Kong DS, et al.: Treatment modalities and outcomes for asymptomatic meningiomas.

Acta Neurochir (Wien) 153: 62–67; discussion 67,

2011

9) Kim KH, Kang SJ, Choi JW, et al.: Clinical and radiological outcomes of proactive Gamma Knife surgery

for asymptomatic meningiomas compared with the

natural course without intervention. J Neurosurg

130: 1740–1749, 2018

10) Kuratsu J, Kochi M, Ushio Y: Incidence and clinical

features of asymptomatic meningiomas. J Neurosurg

92: 766–770, 2000

11) Nakasu S, Fukami T, Nakajima M, Watanabe K,

Ichikawa M, Matsuda M: Growth pattern changes

of meningiomas: long-term analysis. Neurosurgery

56: 946–955, 2005

12) Niiro M, Yatsushiro K, Nakamura K, Kawahara Y,

Kuratsu J: Natural history of elderly patients with

asymptomatic meningiomas. J Neurol Neurosurg

Psychiatry 68: 25–28, 2000

13) Oya S, Kim SH, Sade B, Lee JH: The natural history

of intracranial meningiomas. J Neurosurg 114:

1250–1256, 2011

14) Braunstein JB, Vick NA: Meningiomas: the decision

not to operate. Neurology 48: 1459–1462, 1997

120

S. Nakasu et al.

15) Go RS, Taylor BV, Kimmel DW: The natural history

of asymptomatic meningiomas in Olmsted County,

Minnesota. Neurology 51: 1718–1720, 1998

16) Herscovici Z, Rappaport Z, Sulkes J, Danaila L,

Rubin G: Natural history of conservatively treated

meningiomas. Neurology 63: 1133–1134, 2004

17) Jadid KD, Feychting M, Höijer J, Hylin S, Kihlström L,

Mathiesen T: Long-term follow-up of incidentally

discovered meningiomas. Acta Neurochir (Wien)

157: 225–230; discussion 230, 2015

18) Olivero WC, Lister JR, Elwood PW: The natural

history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 83:

222–224, 1995

19) Romani R, Ryan G, Benner C, Pollock J: Non-operative

meningiomas: long-term follow-up of 136 patients.

Acta Neurochir (Wien) 160: 1547–1553, 2018

20) Rubin G, Herscovici Z, Laviv Y, Jackson S, Rappaport

ZH: Outcome of untreated meningiomas. Isr Med

Assoc J 13: 157–160, 2011

21) Sonoda Y, Sakurada K, Saino M, Kondo R, Sato S,

Kayama T: Multimodal strategy for managing meningiomas in the elderly. Acta Neurochir (Wien) 147:

131–136; discussion 136, 2005

22) Yano S, Kuratsu J: Indications for surgery in patients

with asymptomatic meningiomas based on an extensive experience. J Neurosurg 105: 538–543, 2006

23) Lee EJ, Kim JH, Park ES, et al.: A novel weighted

scoring system for estimating the risk of rapid

growth in untreated intracranial meningiomas.

J Neurosurg 127: 971–980, 2017

24) Lee EJ, Park JH, Park ES, Kim JH: “Wait-and-See”

strategies for newly diagnosed intracranial meningiomas based on the risk of future observation

failure. World Neurosurgery 107: 604–611, 2017

25) Nakamura M, Roser F, Michel J, Jacobs C, Samii M:

The natural history of incidental meningiomas.

Neurosurgery 53: 62–70; discussion 70–71, 2003

26) Nakasu S, Onishi T, Kitahara S, Oowaki H, Matsumura

KI: CT Hounsfield unit is a good predictor of growth

in meningiomas. Neurol Med Chir (Tokyo) 59:

54–62, 2019

27) Yoneoka Y, Fujii Y, Tanaka R: Growth of incidental

meningiomas. Acta Neurochir (Wien) 142: 507–511,

2000

28) Nakasu S, Nakasu Y, Fukami T, Jito J, Nozaki K:

Growth curve analysis of asymptomatic and symptomatic meningiomas. J Neurooncol 102: 303–310,

2011

29) Chang V, Narang J, Schultz L, et al.: Computeraided volumetric analysis as a sensitive tool for

the m

­ anagement of incidental meningiomas. Acta

Neurochir (Wien) 154: 589–597; discussion 597, 2012

30) Zeidman LA, Ankenbrandt WJ, Du H, Paleologos N,

Vick NA: Growth rate of non-operated meningiomas.

J Neurol 255: 891–895, 2008

31) Webplotdigitizer: https://automeris.io/WebPlotDigitizer/

(Accessed on 2019 Mar. 28)

32) Kanda Y: Investigation of the freely available easyto-use software ‘EZR’ for medical statistics. Bone

Marrow Transplant 48: 452–458, 2013

33) Hirota K, Fujita T, Akagawa H, Onda H, Kasuya H:

Spontaneous regression together with increased

calcification of incidental meningioma. Surg Neurol

Int 5: 73, 2014

34) Islim AI, Mohan M, Moon RDC, et al.: Incidental

intracranial meningiomas: a systematic review and

meta-analysis of prognostic factors and outcomes.

J Neurooncol 142: 211–221, 2019

35) Kasuya H, Kubo O, Kato K, Krischek B: Histological characteristics of incidentally-found growing

meningiomas. J Med Invest 59: 241–245, 2012

36) Liu Y, Li F, Wang C: Clinical features and surgical

treatment of asymptomatic meningiomas. Turk

Neurosurg 25: 121–125, 2015

37) Ishi Y, Terasaka S, Yamaguchi S, et al.: Reliability

of the size evaluation method for meningiomas:

maximum diameter, ABC/2 formula, and planimetry

method. World Neurosurg 94: 80–88, 2016

38) Zeng L, Liang P, Jiao J, Chen J, Lei T: Will an

asymptomatic meningioma grow or not grow? A

meta-analysis. J Neurol Surg A Cent Eur Neurosurg

76: 341–347, 2015

39) Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ,

McDermott MW, Parsa AT: Treatment decision

making based on the published natural history and

growth rate of small meningiomas. J Neurosurg 113:

1036–1042, 2010

40) Berhouma M, Jacquesson T, Jouanneau E, Cotton F:

Pathogenesis of peri-tumoral edema in intracranial

meningiomas. Neurosurg Rev 42: 59–71, 2019

41) Nakasu S, Nakajima M, Matsumura K, Nakasu Y,

Handa J: Meningioma: proliferating potential and clinic­

oradiological features. Neurosurgery 37: 1049–1055,

1995

Address reprint requests to: Satoshi Nakasu, MD, Division

of Neurosurgery, Kusatsu General Hospital, Yabase

1660, Kusatsu, Shiga 525-8585, Japan.

e-mail: neuro-nakasu@kfx.biglobe.ne.jp

Neurol Med Chir (Tokyo) 60, March, 2020

...

参考文献をもっと見る